NL
NL · NL · NL-4fc7782bdd82
Moxifloxacine VIOSER 400 mg/250 ml oplossing voor infusie
ATC J01MA14
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerVioser S.A. Parenteral Solutions Industry
CountryNL (NL)
ATC codeJ01MA14
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_id118540
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118540_smpc.pdf",
"strength": null,
"atc_label": "Moxifloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118540",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"NATRIUMSULFAAT 0-WATER (E 514 (I))",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE"
],
"substances": [
"MOXIFLOXACINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118540.pdf",
"authorised_at": "2017/02/20",
"procedure_number": "NL/H/3664/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "118540",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code J01MA14.
Access this data programmatically
Query Moxifloxacine VIOSER 400 mg/250 ml oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.